IndraLab

Statements

Salsalate inhibits NFKB1. 2 / 2
| 2
reach
"Both ADA and AACE recommend that following lifestyle changes and metformin, we should preferentially use these therapies if subjects with diabetes have established ASCVD.In this regard it needs to be [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
30514609
reach
"For example, Salsalate is broadly thought to inhibit NF-KB and showed efficacy in a recent trial [XREF_BIBR]."
28752547